What's New

Evolent co-founder and new CEO Seth Blackley explains how the company is positioned to deliver for each of its stakeholders

Whether it's rapidly detecting fraud, waste and abuse or quickly adopting new generic medications, a nimble pharmacy benefit manager can drive drug savings for health plans.

Catch up on the latest trends, deals, innovations and policies shaping the transition to value.

Integration supports better care, member experience and cost control.

A compilation of infection prevention resources, regulatory updates and other industry developments to help your organization respond to this pandemic.

Evolent Health’s Emily Rafferty and Michael Miller share reasons to consider choosing a new administrative platform.

Performing a patient’s annual medication review, Evolent Clinical Pharmacist Avani Arora recognized a vital missing drug and quickly addressed the issue.

Medicare beneficiaries in Evolent’s care management programs had fewer hospitalizations and lower health costs.

Evolent Health's Ashley Ridlon co-authors a Bloomberg Law article explaining how COVID-19 is making a case for the move to value-based care.

Several criteria can help determine whether a PBM is truly willing to bend to meet a plan’s goals.

Behavioral Health Specialist Teena Lovern takes a whole-person approach to help patients facing challenges on multiple fronts.

As pent-up demand releases into the health care system, plans and providers need to quickly reassess patient populations. A well-run risk adjustment program can be a major asset in that effort.

Catch up on two-plus months of deals, innovations and policies affecting the world of value, including the rapid changes spurred by the COVID-19 pandemic.

Evolent's April Womack facilitates a virtual visit, and later a socially distanced house call, for a patient with breathing problems and suspected COVID-19.

Evolent shares detailed approach to identifying and engaging individuals at highest risk of COVID-19, so others can leverage the information in their own identification and outreach efforts.

When a patient did not receive critical medications for her respiratory problems, Evolent Health's Linda Cassidy stepped in to help close the gap.

Evolent is combining clinical data, social determinants of health and the latest evidence about COVID-19 to identify and outreach individuals at the greatest risk of severe outcomes from the disease.

Evolent's Sara Plucker helped a man with multiple chronic diseases obtain important medications and avoid out-of-pocket pharmacy costs as COVID-19 threatened his community.

Across Evolent, we are focused on protecting high-risk members and patients, advocating for independent physicians, and supporting our people.